Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TALLER: TJ101 in Pediatric Growth Hormone Deficiency
NCT04633057Phase 3Completed
- Sponsor
- TJ Biopharma
- Start
- Jan 2021
- Primary completion
- Jul 2023
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of eftansomatropin alfa in growth hormone deficiency (GHD), sponsored by TJ Biopharma. Started Jan 2021; status: completed.
02
Drugs
eftansomatropin alfa
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT04633057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04633057.